Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia

American Journal of Respiratory and Critical Care Medicine

Volumn 176, Issue 4, 2007, Pages 343-349

  Nonoyama, Mika L ^a,b   Brooks, Dina ^a,b   Guyatt, Gordon H ^c   Goldstein, Roger S ^a,b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b WEST PARK HEALTHCARE CENTRE   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Chronic obstructive pulmonary disease; Exertion; Oxygen; Placebo

Indexed keywords

OXYGEN; PLACEBO;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY QUESTIONNAIRE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE DURATION; DYSPNEA; EMOTION; EXERCISE TEST; FATIGUE; FEMALE; HOME CARE; HUMAN; HYPOXEMIA; LONG TERM CARE; MALE; MORTALITY; OXYGEN THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; ST GEORGE RESPIRATORY QUESTIONNAIRE;

AGED; AMBULATORY CARE; ANOXEMIA; DOUBLE-BLIND METHOD; DYSPNEA; EXERCISE TOLERANCE; EXERTION; FEMALE; HUMANS; MALE; OXYGEN INHALATION THERAPY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 34547960768     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200702-308OC     Document Type: Article

References (47)

1. Celli BR, MacNee W; American Thoracic Society/European Respiratory Society Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-946.
2. Wedzicha W, Pearson M. Outcome measures in COPD: what is success? In: Wedzicha W, Pearson M, editors. Chronic obstructive pulmonary disease: critical debates. Malden, MA: Blackwell Science; 2003. pp. 227-240.
3. Reardon JZ, Lareau SC, ZuWallack R. Functional status and quality of life in chronic obstructive pulmonary disease. Am J Med 2006;119(10, Suppl 1):32-37.
4. Weaver TE, Richmond TS, Narsavage GL. An explanatory model of functional status in chronic obstructive pulmonary disease. Nurs Res 1997;46:26-31.
5. O'Donnell DE, Aaron S, Bourbeau J, Hernandez P, Marciniuk D, Balter M, Ford G, Gervais A, Goldstein R, Hodder R, et al.; Canadian Thoracic Society. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2003. Can Respir J 2003;10:183-185.
6. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; Gold Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) [Workshop summary].Am J Respir Crit Care Med 2001;163:1256-1276.
7. The COPD Guidelines Group of the Standards of Care Committee of the BTS. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997;52(Suppl 5):S1-S28.
8. American Thoracic Society; European Respiratory Society. Standards for the diagnosis and management of patients with COPD. New York and Lausanne, Switzerland: American Thoracic Society and European Respiratory Society; 2004.
9. Crockett AJ, Cranston JM, Moss JR, Alpers JH. Domiciliary oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005;4;CD001744.
10. Ram FS, Wedzicha JA. Ambulatory oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2002;1:CD000238.
11. Bradley JM, O'Neill B. Short term ambulatory oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005;2:CD004356.
12. Guyatt GH, Thompson PJ, Berman LB, Sullivan MJ, Townsend M, Jones NL, Pugsley SO. How should we measure function in patients with chronic heart and lung disease? J Chronic Dis 1985;38:517-524.
13. Pilling J, Cutaia M. Ambulatory oximetry monitoring in patients with severe COPD: a preliminary study. Chest 1999;116:314-321.
14. Fussell KM, Ayo DS, Branca P, Rogers JT, Rodriguez M, Light RW. Assessing need for long-term oxygen therapy: a comparison of conventional evaluation and measures of ambulatory oximetry monitoring. Respir Care 2003;48:115-119.
15. Eaton T, Garrett JE, Young P, Fergusson W, Kolbe J, Rudkin S, Whyte K. Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study. Eur Respir J 2002;20:306-312.
16. Lacasse Y, Lecours R, Pelletier C, Begin R, Maltais F. Randomised trial of ambulatory oxygen in oxygen-dependent COPD. Eur Respir J 2005;25:1032-1038.
17. Lilker ES, Karnick A, Lerner L. Portable oxygen in chronic obstructive lung disease with hypoxemia and cor pulmonale: a controlled doubleblind crossover study. Chest 1975;68:236-241.
18. McDonald CF, Blyth CM, Lazarus MD, Marschner I, Barter CE. Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxemia. Am J Respir Crit Care Med 1995;152:1616-1619.
19. Guyatt G, Sackett D, Taylor DW, Chong J, Roberts R, Pugsley S. Determining optimal therapy-randomized trials in individual patients. N Engl J Med 1986;314:889-892.
20. American Thoracic Society Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-117.
21. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1980;93:391-398.
22. Guyatt GH, Keller JL, Jaeschke R, Rosenbloom D, Adachi JD, Newhouse MT. The n-of-1 randomized controlled trial: clinical usefulness: our three-year experience. Ann Intern Med 1990;112:293-299.
23. Guyatt GH, McKim DA, Weaver B, Austin PA, Bryan RE, Walter SD, Nonoyama ML, Ferreira IM, Goldstein RS. Development and testing of formal protocols for oxygen prescribing. Am J Respir Crit Care Med 2001;163:942-946.
24. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987;42:773-778.
25. Lacasse Y, Wong E, Guyatt G, Goldstein RS.Health status measurement instruments in chronic obstructive pulmonary disease. Can Respir J 1997;4:152-164.
26. Jones PW, Quirk FFH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: the St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-1327.
27. Jones P, Quirk F, Baveystock C. The St. George's Respiratory Questionnaire. Respir Med 1991;85:25-31.
28. Schunemann HJ, Griffith L, Jaeschke R, Goldstein R, Stubbing D, Guyatt GH. Evaluation of the minimal important difference for the feeling thermometer and the St. George's Respiratory Questionnaire in patients with chronic airflow obstruction. J Clin Epidemiol 2003;56:1170-1176.
29. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14:377-381.
30. American Thoracic Society; American College of Chest Physicians. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003;167:211-277.
31. Jones NL. Clinical exercise testing, 4th ed. Philadelphia: W.B. Saunders; 1997.
32. Shrout P, Fleiss J. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86:420-428.
33. Young P, Dewse M, Fergusson W, Kolbe J. Improvements in outcomes for chronic obstructive pulmonary disease (COPD) attributable to a hospital-based respiratory rehabilitation programme. Aust N Z J Med 1999;29:59-65.
34. Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Quantifying physical activity in daily life with questionnaires and motion sensors in COPD. Eur Respir J 2006;27:1040-1055.
35. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171:972-977.
36. Steele BG, Belza B, Cain K, Warms C, Coppersmith J, Howard J. Bodies in motion: monitoring daily activity and exercise with motion sensors in people with chronic pulmonary disease. J Rehabil R D 2003;40(Suppl 2):45-58.
37. Guyatt GH, Heyting A, Jaeschke R, Keller J, Adachi JD, Roberts RS. N of 1 randomized trials for investigating new drugs. Control Clin Trials 1990;11:88-100.
38. Guyatt G, Jaeschke R, McGinn T. 2B1 therapy and validity: N of 1 randomized controlled trials. In: Guyatt GH, Rennie D, editors. Users' guide to the medical literature. Chicago: American Medical Association; 2002. pp. 275-290.
39. Wedzicha JA. Domiciliary oxygen therapy services: clinical guidelines and advice for prescribers. Summary of a report of the Royal College of Physicians. J R Coll Physicians Lond 1999;33:445-447.
40. Ontario Ministry of Health and Long Term Care Assistive Devices Program. Home Oxygen Program (HOP) administration manual [database on the Internet]. Toronto, Canada: Ontario Ministry of Health and Long Term Care Assistive Devices Program; Available from: http://www.health.gov.on.ca/english/providers/pub/adp/ hop_manual05.pdf (accessed December 10, 2006).
41. Easton PA, Brooks C, Sutherland MF, Chan M. Exercise dependent hypoxemia testing and treatment in a population [abstract]. Eur Respir J 2004;24(Suppl 48):294s.
42. GOLD Executive Committee; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: workshop report. Edgewater, NJ: MCR Vision; 2006.
43. Office of Research Development and Information. Health care industry market update: home health. Baltimore, MD: Centers for Medicare and Medicaid Services; 2003.
44. Petty TL, O'Donohue WJ Jr. Further recommendations for prescribing, reimbursement, technology development, and research in long-term oxygen therapy. Summary of the Fourth Oxygen Consensus Conference, Washington, DC, October 15-16, 1993. Am J Respir Crit Care Med 1994;150:875-877.
45. Andersson A, Strom K, Brodin H, Alton M, Boman G, Jakobsson P, Lindberg A, Uddenfeldt M, Walter H, Levin LA. Domiciliary liquid oxygen versus concentrator treatment in chronic hypoxaemia: a costutility analysis. Eur Respir J 1998;12:1284-1289.
46. O'Neill B, Bradley JM, Heaney L, O'Neill C, MacMahon J. Short burst oxygen therapy in chronic obstructive pulmonary disease: a patient survey and cost analysis. Int J Clin Pract 2005;59:751-753.
47. Larson EB, Ellsworth AJ, Oas J. Randomized clinical trials in single patients during a 2-year period. JAMA 1993;270:2708-2712.